Formoterol Fumarate Patent Expiration
Formoterol Fumarate is Used for managing symptoms and improving lung function in individuals with chronic obstructive pulmonary disease. It was first introduced by Novartis Pharmaceuticals Corp
Formoterol Fumarate Patents
Given below is the list of patents protecting Formoterol Fumarate, along with the drug name that holds that patent and the company name owning that drug.
| Drug Used in | Drug Patent Number | Drug Patent Title | Drug Patent Expiry | Drug Owner |
|---|---|---|---|---|
| Perforomist | US6667344 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Perforomist | US6814953 | Bronchodilating compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Perforomist | US7348362 | Bronchodilating β-agonist compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Perforomist | US7462645 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Perforomist | US8623922 | Bronchodilating Beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Perforomist | US9730890 | Bronchodilating beta-agonist compositions and methods |
Jun 22, 2021
(Expired) | Viatris Specialty |
| Foradil | US6887459 | Aerosol composition comprising formoterol |
Nov 28, 2020
(Expired) | Novartis |
| Foradil | US6488027 | Powder inhaler |
Mar 08, 2019
(Expired) | Novartis |
Formoterol Fumarate's Family Patents
Explore Our Curated Drug Screens
Drugs Generating Over $1 Billion in Annual Revenue
Explore the top-performing drugs that dominate the pharmaceutical industry
View List
NCE-1 Patent Expiry in the Next 1 Year
Identify opportunities as new chemical entity (NCE-1) patents approach expiry
View List
Recently Granted Patents in EP
Find the opportunity to file Oppositions
View List